Japan· JP-2399010F2024
モサプリドクエン酸塩水和物
A mosapride product containing モサプリドクエン酸塩水和物, registered in Japan by 住友ファーマ, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- モサプリドクエン酸塩水和物
- Manufacturer
- 住友ファーマ
- Country
- Japan (JP)
- ATC code
- A03FA09
- ATC class
- Mosapride
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A03FA09
Mosapride, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fb71e2e6-6f85-4d63-81fa-1a98d198896e GET /v1/drugs/fb71e2e6-6f85-4d63-81fa-1a98d198896e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "５ｍｇ１錠",
"marks": "局",
"source": "mhlw",
"remarks": null,
"yj_code": "2399010F2024",
"category": "内用薬",
"price_yen": 10.8,
"generic_name": "モサプリドクエン酸塩水和物",
"product_name_jp": null,
"therapeutic_class": "2399",
"transitional_expiry": null
}See everything about mosapride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.